Taking everything into account, TCRX scores 2 out of 10 in our fundamental rating. TCRX was compared to 525 industry peers in the Biotechnology industry. The financial health of TCRX is average, but there are quite some concerns on its profitability. While showing a medium growth rate, TCRX is valued expensive at the moment.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year TCRX has reported negative net income.
In the past year TCRX has reported a negative cash flow from operations.
In the past 5 years TCRX always reported negative net income.
In the past 5 years TCRX always reported negative operating cash flow.

1.2 Ratios

TCRX has a Return On Assets of -54.38%. This is comparable to the rest of the industry: TCRX outperforms 46.10% of its industry peers.
TCRX has a Return On Equity of -99.01%. This is comparable to the rest of the industry: TCRX outperforms 46.10% of its industry peers.

		Industry Rank	Sector Rank
ROA	-54.38%
ROE	-99.01%
ROIC	N/A

ROA(3y)-33.47%

ROA(5y)-35.77%

ROE(3y)-59.56%

ROE(5y)-72.17%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TCRX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TCRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TCRX has more shares outstanding
TCRX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, TCRX has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -3.34, we must say that TCRX is in the distress zone and has some risk of bankruptcy.
TCRX's Altman-Z score of -3.34 is in line compared to the rest of the industry. TCRX outperforms 44.57% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that TCRX is not too dependend on debt financing.
TCRX has a worse Debt to Equity ratio (0.23) than 65.71% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.23
Debt/FCF	N/A
Altman-Z	-3.34

ROIC/WACCN/A

WACC9.43%

2.3 Liquidity

TCRX has a Current Ratio of 6.44. This indicates that TCRX is financially healthy and has no problem in meeting its short term obligations.
TCRX has a Current ratio of 6.44. This is in the better half of the industry: TCRX outperforms 66.29% of its industry peers.
TCRX has a Quick Ratio of 6.44. This indicates that TCRX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 6.44, TCRX is in the better half of the industry, outperforming 66.86% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	6.44
Quick Ratio	6.44

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for TCRX have decreased by -5.66% in the last year.
TCRX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.03%.
The Revenue for TCRX have been decreasing by -34.76% on average. This is quite bad

EPS 1Y (TTM)-5.66%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-12%

Revenue 1Y (TTM)-10.03%

Revenue growth 3Y-34.76%

Revenue growth 5YN/A

Sales Q2Q%139.37%

3.2 Future

The Earnings Per Share is expected to grow by 8.04% on average over the next years. This is quite good.
Based on estimates for the next years, TCRX will show a very strong growth in Revenue. The Revenue will grow by 71.81% on average per year.

EPS Next Y4.68%

EPS Next 2Y9.82%

EPS Next 3Y7.51%

EPS Next 5Y8.04%

Revenue Next Year207.63%

Revenue Next 2Y50.62%

Revenue Next 3Y56.74%

Revenue Next 5Y71.81%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

TCRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TCRX. No positive earnings are expected for the next year.